IBDEI0WM ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16107,0)
 ;;=784.8^^92^933^5
 ;;^UTILITY(U,$J,358.3,16107,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16107,1,4,0)
 ;;=4^784.8
 ;;^UTILITY(U,$J,358.3,16107,1,5,0)
 ;;=5^Bleeding From Throat
 ;;^UTILITY(U,$J,358.3,16107,2)
 ;;=^273371
 ;;^UTILITY(U,$J,358.3,16108,0)
 ;;=373.00^^92^933^6
 ;;^UTILITY(U,$J,358.3,16108,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16108,1,4,0)
 ;;=4^373.00
 ;;^UTILITY(U,$J,358.3,16108,1,5,0)
 ;;=5^Blepharitis NOS
 ;;^UTILITY(U,$J,358.3,16108,2)
 ;;=^15271
 ;;^UTILITY(U,$J,358.3,16109,0)
 ;;=528.2^^92^933^8
 ;;^UTILITY(U,$J,358.3,16109,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16109,1,4,0)
 ;;=4^528.2
 ;;^UTILITY(U,$J,358.3,16109,1,5,0)
 ;;=5^Canker Sore
 ;;^UTILITY(U,$J,358.3,16109,2)
 ;;=^114480
 ;;^UTILITY(U,$J,358.3,16110,0)
 ;;=112.0^^92^933^7
 ;;^UTILITY(U,$J,358.3,16110,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16110,1,4,0)
 ;;=4^112.0
 ;;^UTILITY(U,$J,358.3,16110,1,5,0)
 ;;=5^Candidiasis, Oral
 ;;^UTILITY(U,$J,358.3,16110,2)
 ;;=^18599
 ;;^UTILITY(U,$J,358.3,16111,0)
 ;;=366.9^^92^933^9
 ;;^UTILITY(U,$J,358.3,16111,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16111,1,4,0)
 ;;=4^366.9
 ;;^UTILITY(U,$J,358.3,16111,1,5,0)
 ;;=5^Cataract NOS
 ;;^UTILITY(U,$J,358.3,16111,2)
 ;;=^20266
 ;;^UTILITY(U,$J,358.3,16112,0)
 ;;=380.4^^92^933^10
 ;;^UTILITY(U,$J,358.3,16112,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16112,1,4,0)
 ;;=4^380.4
 ;;^UTILITY(U,$J,358.3,16112,1,5,0)
 ;;=5^Cerumen Impacton
 ;;^UTILITY(U,$J,358.3,16112,2)
 ;;=^62061
 ;;^UTILITY(U,$J,358.3,16113,0)
 ;;=372.72^^92^933^12
 ;;^UTILITY(U,$J,358.3,16113,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16113,1,4,0)
 ;;=4^372.72
 ;;^UTILITY(U,$J,358.3,16113,1,5,0)
 ;;=5^Conjunctival Hemorrhage
 ;;^UTILITY(U,$J,358.3,16113,2)
 ;;=^27538
 ;;^UTILITY(U,$J,358.3,16114,0)
 ;;=372.30^^92^933^13
 ;;^UTILITY(U,$J,358.3,16114,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16114,1,4,0)
 ;;=4^372.30
 ;;^UTILITY(U,$J,358.3,16114,1,5,0)
 ;;=5^Conjunctivitis NOS
 ;;^UTILITY(U,$J,358.3,16114,2)
 ;;=^27546
 ;;^UTILITY(U,$J,358.3,16115,0)
 ;;=918.1^^92^933^14
 ;;^UTILITY(U,$J,358.3,16115,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16115,1,4,0)
 ;;=4^918.1
 ;;^UTILITY(U,$J,358.3,16115,1,5,0)
 ;;=5^Corneal Abrasion
 ;;^UTILITY(U,$J,358.3,16115,2)
 ;;=^115829
 ;;^UTILITY(U,$J,358.3,16116,0)
 ;;=784.7^^92^933^22
 ;;^UTILITY(U,$J,358.3,16116,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16116,1,4,0)
 ;;=4^784.7
 ;;^UTILITY(U,$J,358.3,16116,1,5,0)
 ;;=5^Nosebleed
 ;;^UTILITY(U,$J,358.3,16116,2)
 ;;=Nosebleed^41658
 ;;^UTILITY(U,$J,358.3,16117,0)
 ;;=365.9^^92^933^16
 ;;^UTILITY(U,$J,358.3,16117,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16117,1,4,0)
 ;;=4^365.9
 ;;^UTILITY(U,$J,358.3,16117,1,5,0)
 ;;=5^Glaucoma NOS
 ;;^UTILITY(U,$J,358.3,16117,2)
 ;;=^51160
 ;;^UTILITY(U,$J,358.3,16118,0)
 ;;=389.9^^92^933^17
 ;;^UTILITY(U,$J,358.3,16118,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16118,1,4,0)
 ;;=4^389.9
 ;;^UTILITY(U,$J,358.3,16118,1,5,0)
 ;;=5^Hearing Loss
 ;;^UTILITY(U,$J,358.3,16118,2)
 ;;=^54552
 ;;^UTILITY(U,$J,358.3,16119,0)
 ;;=465.0^^92^933^18
 ;;^UTILITY(U,$J,358.3,16119,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16119,1,4,0)
 ;;=4^465.0
 ;;^UTILITY(U,$J,358.3,16119,1,5,0)
 ;;=5^Laryngopharyngitis,Acute
 ;;^UTILITY(U,$J,358.3,16119,2)
 ;;=^269876
 ;;^UTILITY(U,$J,358.3,16120,0)
 ;;=386.00^^92^933^19
 ;;^UTILITY(U,$J,358.3,16120,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16120,1,4,0)
 ;;=4^386.00
 ;;^UTILITY(U,$J,358.3,16120,1,5,0)
 ;;=5^Meniere's Disease
 ;;^UTILITY(U,$J,358.3,16120,2)
 ;;=^75724
